Balaxi Pharmaceuticals
BALAXINSE

Balaxi Pharmaceuticals

₹26.43-0.43 (1.60%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
25.70
Today’s high
27.76
52 week low
15.20
52 week high
63.90
Open price
27.76
Previous close
26.86
Live volume
20,250
Lower circuit
25.52
Upper circuit
28.20

Fundamentals

Market Cap
₹148Cr
ROE
6.09%
P/E Ratio(TTM)
15.71
EPS(TTM)
1.71
P/B Ratio
0.62
Dividend Yield
0.00%
Industry P/E
34.55
Book Value
43.12
Debt to Equity
0.24
Face Value
2

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹72.64
+25.74%
Profit (Cr)
₹0.31
+47.62%
020406080
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-6%
3Y CAGR+1%
Profit growthValue
1Y (TTM)-94%
3Y CAGR-19%

About

Balaxi Pharmaceuticals is a globally recognized company enhancing healthcare by providing a wide range of pharmaceuticals in the frontier markets of Latin America and Africa. Its vision is to establish strong product portfolios and channel networks, aiming to expand into 20 frontier markets over the next 5 years. The company's mission is to become a top pharmaceutical player in these markets, focusing on scale, healthy margins, and quality growth in a balanced way. Its diverse portfolio includes a well-balanced mix of generics and branded generics, with products like antibiotics, analgesics, and anti-malaria drugs. As part of its backward integration strategies, it is establishing a pharmaceutical formulation facility in Hyderabad, India to ensure quality and reduce dependency. The company has an impressive track record of 960 product registrations in multiple countries, with another 700 underway to expand its presence.;
CEO/MD
Mr. Ashish Maheshwari
Founded in
1942
NSE symbol
BALAXI

Shareholding Pattern

Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Promoters
65.99%
Retail And Others
31.45%
Other Domestic Institutions
2.56%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹373.00
-4.50 (1.19%)
L
    H
    4,113.4485.9915.56
    ₹399.50
    -4.55 (1.13%)
    L
      H
      3,775.5842.135.18
      Orchid PharmaORCHPHARMA
      ₹719.25
      +23.70 (3.41%)
      L
        H
        3,525.74186.872.77
        Aarti DrugsAARTIDRUGS
        ₹362.35
        -5.50 (1.50%)
        L
          H
          3,349.6116.552.28
          2026
          28
          May
          Quarterly & Annual Result
          Upcoming
          Release date
          28
          Jan
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          5
          Aug
          Quarterly Result
          Release date
          2024

          30
          May
          Split
          Ex date
          2:10
          Ratio

          For each share you hold, you will receive 5 shares with face value of ₹2.0 each
          Split Ratio2:10
          Ex date30 May ‘24
          Record date30 May ‘24
          Announcement date28 Feb ‘24
          Events calendar
          View upcoming events in other stocks